<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000594104"><TermName>Treanda</TermName><TermPronunciation>(tree-AN-duh)</TermPronunciation><TermDefinition><DefinitionText>A drug used to treat chronic lymphocytic leukemia (CLL). It is also used to treat slow-growing B-cell non-Hodgkin lymphoma (NHL) that has gotten worse within 6 months of treatment with other anticancer drugs. It is being studied in the treatment of other types of cancer. Treanda may damage the DNA in cancer cells and cause them to die. It is a type of alkylating agent and a type of antimetabolite.  Also called bendamustine hydrochloride.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000720503" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Treanda&quot;" language="en" id="_3"/><MediaLink ref="CDR0000720502" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Treanda&quot;" language="es" id="_4"/><SpanishTermName>Treanda</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para tratar la leucemia linfocítica crónica (LLC). También se usa para tratar el linfoma no Hodgkin (LNH) de células B de crecimiento lento que empeoró dentro de los seis meses de tratamiento con otros medicamentos contra el cáncer. Está en estudio para el tratamiento de otros tipos de cáncer. Treanda puede dañar el ADN de las células cancerosas y destruirlas. Es un tipo de alquilante y un tipo de antimetabolito. También se llama clorhidrato de bendamustina.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2008-04-14</DateFirstPublished><DateLastModified>2014-12-10</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000592692">Bendamustine Hydrochloride</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
